(Q50124393)

25 February 2018

title

Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms. (English)

1 reference

25 February 2018

author name string

Shetty SK

1

1 reference

25 February 2018

Rosen MP

2

1 reference

25 February 2018

Raptopoulos V

3

1 reference

25 February 2018

Goldberg SN

4

1 reference

25 February 2018

publication date

1 July 2001

1 reference

25 February 2018

Journal of Vascular and Interventional Radiology

published in

1 reference

25 February 2018

volume

12

1 reference

25 February 2018

issue

7

1 reference

25 February 2018

page(s)

823-833

1 reference

25 February 2018

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Factors influencing the natural history of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Surgical treatment of liver metastases in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Therapeutic modalities and prognostic factors for primary and secondary liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

New applications of ultrasonography: interventional ultrasound.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Radiofrequency thermal ablation of liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Ablation of liver tumors using percutaneous RF therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Bedside placement of peripherally inserted central catheters: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961507-3

7 January 2021

10.1016/S1051-0443(07)61507-3

Identifiers

DOI

1 reference

25 February 2018

release_aetjahn2nrau5e3enswp45md3e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aetjahn2nrau5e3enswp45md3e

24 November 2022

mapped directly with Wikidata item

PubMed ID

11435538

1 reference

25 February 2018